mRNA-based Influenza B vaccine (Acuitas Therapeutics/University of Pennsylvania/Icahn School of Medicine at Mount Sinai/Biological Research Center)

N/A

报告时间: 2025/12/18 17:46:46

基本信息

药物名称mRNA-based Influenza B vaccine (Acuitas Therapeutics/University of Pennsylvania/Icahn School of Medicine at Mount Sinai/Biological Research Center)

药物别称lipid nanoparticle-encapsulated nucleoside-modified mRNA vaccine (Acuitas Therapeutics/University of Pennsylvania/Icahn School of Medicine at Mount Sinai/Biological Research Center)pentavalent nucleoside-modified mRNA vaccine (Acuitas Therapeutics/University of Pennsylvania/Icahn School of Medicine at Mount Sinai/Biological Research Center)

药物类型疫苗 > 研制/生产技术 > 核酸疫苗 > RNA疫苗疫苗 > 用途 > 预防性疫苗

作用机制血凝素调节剂

靶点血凝素

治疗领域 / 适应症乙型流感病毒感染

全球批准适应症N/A

中国批准适应症N/A

首批国家/区域N/A

首批日期N/A

国家/区域加拿大美国匈牙利

是否复方否

全球最高研发状态临床前

中国最高研发状态N/A

原研公司宾夕法尼亚大学

注册分类N/A

研发信息

活跃公司Biological Research Center of the Hungarian Academy of Sciences Acuitas Therapeutics Inc Icahn School Of Medicine At Mount Sinai +[4]

非活跃公司N/A

活跃适应症乙型流感病毒感染

非活跃适应症N/A

其他信息

ATC代码N/A